Teza Capital Management LLC Buys New Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Teza Capital Management LLC bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 1,940 shares of the medical equipment provider's stock, valued at approximately $1,013,000.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Bennett Selby Investments LP grew its stake in Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock valued at $234,000 after acquiring an additional 17 shares in the last quarter. Onefund LLC grew its stake in Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock valued at $494,000 after acquiring an additional 18 shares in the last quarter. LVW Advisors LLC grew its stake in Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock valued at $756,000 after acquiring an additional 19 shares in the last quarter. Wesbanco Bank Inc. grew its stake in Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock valued at $635,000 after acquiring an additional 19 shares in the last quarter. Finally, FSM Wealth Advisors LLC grew its stake in Intuitive Surgical by 3.7% during the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider's stock valued at $275,000 after acquiring an additional 19 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Down 1.8%

Shares of ISRG stock traded down $10.09 during trading hours on Wednesday, reaching $547.07. 1,507,121 shares of the company's stock were exchanged, compared to its average volume of 1,645,687. Intuitive Surgical, Inc. has a fifty-two week low of $396.15 and a fifty-two week high of $616.00. The stock has a market capitalization of $196.08 billion, a P/E ratio of 85.35, a P/E/G ratio of 5.85 and a beta of 1.70. The business has a fifty day moving average price of $509.36 and a 200-day moving average price of $537.43.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same period in the previous year, the company earned $1.50 earnings per share. As a group, research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Royal Bank of Canada lowered their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Wells Fargo & Company boosted their price target on Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Piper Sandler lowered their price target on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. Raymond James boosted their price target on Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Finally, Citigroup boosted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research note on Friday, January 24th. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $598.95.

Insider Transactions at Intuitive Surgical

In related news, EVP Myriam Curet sold 2,401 shares of the company's stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $581.00, for a total value of $1,394,981.00. Following the completion of the transaction, the executive vice president now directly owns 353 shares in the company, valued at approximately $205,093. This represents a 87.18% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the company's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the transaction, the director now owns 6,371 shares of the company's stock, valued at $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 32,700 shares of company stock worth $16,865,621 over the last three months. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.